This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
- Investigators
- Carla Zingariello, Sub Subramony
- Status
- Accepting Candidates
- Ages
- 12 Years - 50 Years
- Sexes
- All
Carla Zingariello, DO
Neuromuscular Medicine Specialist, Pediatric Neurologist, Pediatric Neuromuscular Rehabilitation Specialist
Research at a glance
Top areas of exploration
- Ataxia , 2 publications
- Muscular Dystrophy, Duchenne , 2 publications
- Intracellular Signaling Peptides and Proteins , 1 publications
- Disease Progression , 1 publications
Research activity
Focus
Dr. Zingariello is actively involved in research in her field. She is currently the Principal Investigator on a muscular dystrophy grant from CDC to University of Florida. She also serves as PI for a Limb Girdle muscular dystrophy clinical trial. She has a Children’s Miracle Network grant to investigate factors contributing to delays in diagnosis of juvenile myasthenia gravis and spinal muscular atrophy. She additionally serves as a sub-Investigator on multiple gene therapy clinical trials for Duchenne Muscular Dystrophy.
Active clinical trials
This study will evaluate the safety and efficacy of long-term administration of BBP-418 in patients with LGMD2I/R9. The study will include patients ages 12 to 60, consistent with the existing preclinical toxicology profile. This will encompass the…
- Investigators
- Carla Zingariello, S Parrish Winesett
- Status
- Accepting Candidates
- Ages
- 12 Years - 60 Years
- Sexes
- All
My publications
Filter publications
13 publications
2025
Time Release Ion Matrix Regenerates Dystrophic Skeletal Muscle.
Research square
•2024
Skeletal muscle symptoms and quantitative MRI in females with dystrophinopathy
Muscle & Nerve
2024
Assessing Long-Term Neurologic Outcomes in SAMD9L-Related Ataxia-Pancytopenia Syndrome.
Movement disorders clinical practice
•2024
Diagnoses of muscular dystrophy in a veterans health system
Muscle & Nerve
2023
Polysomnography findings in children with spinal muscular atrophy after onasemnogene-abeparvovec.
Sleep medicine
•